SINGER DAVID B 4
4 · Churchill Capital Corp X/Cayman · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Infleqtion (INFQ) Director David B. Singer Receives Award
What Happened
David B. Singer, a director of Infleqtion, Inc. (ticker INFQ; formerly Churchill Capital Corp X/Cayman), was issued equity in connection with the company’s merger on February 13, 2026. The Form 4 reports two derivative awards: 34,740 shares (listed with price N/A) and 29,950 derivative shares/options with a $0.00 strike. These awards were recorded as acquisitions (code A) and are derivative securities rather than open-market purchases or sales. One award is noted as fully vested; the other is subject to a time-based vesting schedule.
Key Details
- Transaction date: February 13, 2026; Form 4 filed February 18, 2026 (filed 5 days after transaction — appears late relative to the typical 2-business-day rule).
- Reported awards: 34,740 derivative shares (price N/A) and 29,950 derivative shares/options at $0.00 strike — total 64,690 shares/equivalents.
- Shares owned after transaction: Not specified on the filing.
- Notable footnotes:
- Awards were issued pursuant to the merger and reorganization with ColdQuanta (footnote: merger conversion).
- One award is fully vested; the other’s underlying shares vest 1/3 on Feb 17, 2027 and then 1/36th monthly thereafter (standard time-based vesting).
- Legacy Company stock options were converted into Issuer options with the same terms.
- Economic benefit of the director compensation passes to Maverick Ventures Investment Fund, L.P.; Singer disclaims beneficial ownership except for his pecuniary interest.
- Transaction type: Award/grant of derivative securities (code A), not a cash purchase or sale.
Context
These entries reflect merger-related equity awards and converted legacy options rather than open-market trades. Derivative awards and vested options do not by themselves indicate insider buying/selling sentiment. The time-based vesting on part of the grant means not all shares became immediately transferable. The filing date is later than typical Section 16 timing expectations, which the Form indicates by the later filing date.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1][F3][F2][F4]2026-02-13+34,740→ 34,740 totalExercise: $0.90Exp: 2034-06-05→ Common Stock (34,740 underlying) - Award
Stock Option (Right to Buy)
[F5][F4]2026-02-13+29,950→ 29,950 totalExercise: $13.22Exp: 2036-02-12→ Common Stock (29,950 underlying)
Footnotes (5)
- [F1]Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
- [F2]Fully vested.
- [F3]Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
- [F4]The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
- [F5]1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.